You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 17, 2025

Profile for Austria Patent: 320259


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Austria Patent: 320259

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
7,732,430 Jan 15, 2028 Mayne Pharma NEXTSTELLIS drospirenone; estetrol
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Austria Drug Patent AT320259

Last updated: July 27, 2025


Introduction

Patent AT320259 pertains to a pharmaceutical invention filed in Austria, with potential implications for global patent landscapes depending on its scope and claims. As a drug patent, it provides exclusive rights to the inventor or assignee within Austria, potentially influencing research, development, and commercialization strategies. This analysis dissects the scope and claims of patent AT320259, assesses its standing within the broader patent landscape, and evaluates strategic implications for stakeholders.


Patent Overview and Basic Data

  • Filing and Publication Details:
    Patent AT320259 was filed with the Austrian Patent Office, with publication likely following national or PCT procedures. Depending on the filing date, it could be a granted patent or application status. The patent's legal status, expiration, and grant details are critical to understanding its enforceability scope.

  • Assignee and Inventor Information:
    Data on the patent holder and inventors, typically disclosed in the patent document, helps identify potential patenting strategies, collaboration opportunities, and competitive positioning.


Claims Analysis

Patent claims represent the legal scope of protection and define the boundaries of the patented invention. They can be broadly classified into independent and dependent claims.

1. Nature and Type of Claims

  • Product Claims:
    Likely cover specific chemical compounds, analogs, or formulations. They broadly encompass the active pharmaceutical ingredient (API), its salts, or derivatives.

  • Method Claims:
    Define methods of manufacturing, administering, or using the drug, including dosing regimens or treatment indications.

  • Use Claims:
    Cover specific therapeutic applications, possibly targeting certain diseases, patient populations, or combinatorial therapies.

  • Formulation Claims:
    Address delivery systems, excipients, or specific dosage forms to optimize stability or bioavailability.

2. Claims Language and Scope

  • Broad vs. Narrow Claims:
    Analyzing whether claims are broad (covering general classes or chemical structures) or narrow (specific compounds or specific methods) impacts enforceability and freedom-to-operate evaluations.

  • Essential Elements:
    Claims specify core structural features or process steps critical for patentability (novelty, inventive step, industrial applicability).

  • Potential Overlaps:
    Similarity to existing patents might narrow claim scope or trigger infringement concerns. Prior art searches reveal potential overlaps.

3. Interpretation and Limitations

  • Claim Construction:
    Its language, including definitions, Markush groups, and scope of Markush structures, influences how broadly third parties can operate without infringing.

  • Claim Dependencies:
    Dependent claims refine or specify independent claims, providing fallback positions but reducing overall breadth.

Patent Landscape Assessment

1. Related Patents and Priority Family

  • Priority Applications:
    Identifying any PCT or foreign applications through the patent family offers insight into the global patent coverage.

  • Patent Family Members and International Filings:
    Determining whether similar inventions are protected elsewhere, such as in the EPO, US, or other jurisdictions, is crucial. Active family members suggest strategic protection scope.

2. Patent Overlap and Competition

  • Existing Patents:
    Comparing claims with prior art to identify potential overlaps informs freedom-to-operate analyses.

  • Competitive Patents:
    Patents owned by competitors within the same therapeutic area may pose infringement risks or provide blocking opportunities.

3. Legal Status and Maintenance

  • Validity and Maintenance:
    Ensuring the patent remains in force by paying renewal fees is essential. Any lapse creates opportunities for generic entry.

  • Litigation or oppositions:
    Past legal challenges influence patent strength and enforceability.


Strategic and Commercial Implications

  • A broad set of claims confers competitive advantage but may face validity challenges when overly expansive.

  • Narrow claims limit scope but can be more defensible, shaping licensing or partnership strategies.

  • Patent AT320259's landscape positioning affects R&D directions, licensing opportunities, and potential for generic challenges.


Regulatory and Patent Law Context in Austria

Austria's patent law aligns with the European Patent Convention (EPC), and patents are enforceable throughout EPC member states. The scope of claim interpretation adheres to EPC principles, emphasizing the language's ordinary meaning, the description, and the drawings.


Conclusion

Patent AT320259's scope hinges on its claims' breadth, clarity, and the invention's novelty and inventive step concerning prior art. Its landscape involves the patent family, jurisdictional extensions, and competitive patents. Strategic decisions—such as licensing, enforcement, or challenge—depend on these insights.


Key Takeaways

  • Claim Scope is Critical: Broader claims provide wider protection but risk invalidation; narrower claims may limit enforceability but are more defensible.

  • Patent Landscape Requires Holistic View: Identify patent family members and related patents for a comprehensive understanding of the protection scope and potential freedom-to-operate.

  • Legal and Regulatory Environment Matters: Austria's adherence to EPC standards influences claim interpretation and enforceability strategies.

  • Monitoring Maintenance and Legal Status: Ensuring the patent remains valid avoids unintentional lapses.

  • Strategic Positioning: Use patent landscape insights to inform R&D, licensing, and commercialization plans.


FAQs

1. How does claim breadth influence enforceability?
Broader claims protect a wider scope but are more vulnerable to prior art challenges; narrow claims can be more defensible but limit coverage.

2. What is the significance of patent family analysis?
It reveals the geographical scope of protection and indicates the patent's strategic importance across markets.

3. How can the patent landscape impact drug development strategies?
Understanding existing patents helps identify opportunities for innovation, avoid infringement, and optimize licensing or partnership opportunities.

4. What factors determine the patent's regulatory success in Austria?
Compliance with EPC standards, novelty, inventive step, and clear claim language are essential for patent grant and enforceability.

5. How do legal challenges affect patent strength?
Oppositions, litigation, or invalidation proceedings can weaken or nullify patent rights, influencing commercialization timelines.


References

  1. European Patent Convention (EPC). European Patent Organisation.
  2. Austria Patent Law. Austrian Patent Office.
  3. Patent AT320259 Documentation. Austrian Patent Office Database.
  4. Patent Strategy Best Practices. WIPO.
  5. Patent Landscape Analysis Frameworks. Deloitte Technology, Media & Telecommunications (TMT) Reports.

Note: The specific details of patent AT320259, including claims language, legal status, and family members, would require access to official patent documents. The above analysis emphasizes generic principles based on typical patent valuation and landscape approaches.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.